INVESTIGATING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early identification of diseases is essential for improving patient outcomes and reducing the burden of chronic conditions. Traditionally, disease screening has relied on physical observations and conventional diagnostic procedures. However, these approaches often fail to identify diseases in their early stages, when intervention is most effective.